These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6938519)
1. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography. Plunkett W; Chubb S; Barlogie B J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519 [No Abstract] [Full Text] [Related]
2. Detection and separation of intracellular 1-beta-D-arabinofuranosylcytosine-5-triphosphate by ion-pair high-performance liquid chromatography. Schleyer E; Ehninger G; Zühlsdorf M; Proksch B; Hiddemann W J Chromatogr; 1989 Dec; 497():109-20. PubMed ID: 2625448 [TBL] [Abstract][Full Text] [Related]
3. Cellular pharmacology and optimal therapeutic concentrations of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic blasts during treatment of refractory leukemia with high-dose 1-beta-D-arabinofuranosylcytosine. Plunkett W; Iacoboni S; Keating MJ Scand J Haematol Suppl; 1986; 44():51-9. PubMed ID: 3457439 [No Abstract] [Full Text] [Related]
4. High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells. Plunkett W; Benvenuto JA; Stewart DJ; Loo TL Cancer Treat Rep; 1979 Mar; 63(3):415-20. PubMed ID: 284846 [TBL] [Abstract][Full Text] [Related]
5. Two simple high-performance liquid chromatographic methods for simultaneous determination of 2'-deoxycytidine 5'-triphosphate and cytosine arabinoside 5'-triphosphate concentrations in biological samples. Danks MK J Chromatogr; 1982 Dec; 233():141-8. PubMed ID: 7161328 [TBL] [Abstract][Full Text] [Related]
7. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells. Ho DH; Carter CJ; Brown NS; Hester J; McCredie K; Benjamin RS; Freireich EJ; Bodey GP Cancer Res; 1980 Jul; 40(7):2444-6. PubMed ID: 6248205 [No Abstract] [Full Text] [Related]
8. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia. Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863 [No Abstract] [Full Text] [Related]
9. Determination of cytosine arabinoside triphosphate in leukemic cells by isocratic high-performance anion-exchange column chromatography. Linssen P; Drenthe-Schonk A; Wessels H; Vierwinden G; Haanen C J Chromatogr; 1982 Nov; 232(2):424-9. PubMed ID: 7153290 [No Abstract] [Full Text] [Related]
10. Relationship between intracellular dCTP/ara-CTP ratio and cytotoxic effect of ara-C. Kawasaki H; Higashigawa M; Ohkubo T; Kamiya H; Sakurai M Adv Exp Med Biol; 1989; 253B():369-74. PubMed ID: 2610125 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-beta-D-arabinofuranosylcytosine. Liliemark JO; Paul CY; Gahrton CG; Peterson CO Cancer Res; 1985 May; 45(5):2373-5. PubMed ID: 3986778 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C). Riva CM; Rustum YM; Preisler HD Semin Oncol; 1985 Jun; 12(2 Suppl 3):1-8. PubMed ID: 3859925 [No Abstract] [Full Text] [Related]
13. Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells. Momparler RL; Onetto-Pothier N; Bouffard DY; Momparler LF Cancer Chemother Pharmacol; 1990; 27(2):141-6. PubMed ID: 2249330 [TBL] [Abstract][Full Text] [Related]
14. Degradation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human leukemic myeloblasts and lymphoblasts. Jamieson GP; Finch LR; Snook M; Wiley JS Cancer Res; 1987 Jun; 47(12):3130-5. PubMed ID: 3472653 [TBL] [Abstract][Full Text] [Related]
15. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W; Hug V; Keating MJ; Chubb S Cancer Res; 1980 Mar; 40(3):588-91. PubMed ID: 6937239 [TBL] [Abstract][Full Text] [Related]
16. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy. Plunkett W; Liliemark JO; Adams TM; Nowak B; Estey E; Kantarjian H; Keating MJ Cancer Res; 1987 Jun; 47(11):3005-11. PubMed ID: 3471322 [TBL] [Abstract][Full Text] [Related]
17. A simple isocratic ion-pair high-performance liquid chromatographic determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate for intracellular drug-monitoring and in vitro incubation assays. Boos J J Pharm Biomed Anal; 1991; 9(1):47-52. PubMed ID: 2043722 [TBL] [Abstract][Full Text] [Related]
18. Prediction of sensitivity to 1-beta-D-arabinofuranosylcytosine by the plateau level of its 5'-triphosphate in human lymphoblastic cell lines in vitro. Abe I; Saito S; Hori K; Suzuki M; Sato H Eur J Cancer Clin Oncol; 1983 Jul; 19(7):941-4. PubMed ID: 6576907 [TBL] [Abstract][Full Text] [Related]
19. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells. Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947 [TBL] [Abstract][Full Text] [Related]
20. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells. Lauzon GJ; Paterson AR; Belch AW Cancer Res; 1978 Jun; 38(6):1730-3. PubMed ID: 274175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]